Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxford Biomedical Technologies offers the patented Mediator Release Test (MRT), a blood-based diagnostic that quantifies inflammatory responses to foods and food chemicals. Combined with their LEAP anti-inflammatory eating plan, these tools have been used in over 40 million assays and are reported to provide rapid relief for patients with IBS, migraine, fibromyalgia, and other chronic conditions linked to diet-induced inflammation. The company has authored multiple U.S. and international patents in this field.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxford Biomedical Technologies.